Protein Structure

在过去的几年里，我们的工作集中在五个不同的领域。蛋白酶的晶体学研究自该科成立以来，蛋白酶的晶体学研究一直是该科的一个重要研究领域。我们一直在研究天冬氨酸蛋白酶的结构-功能关系，包括临床重要的逆转录酶。我们对HIV蛋白酶的研究，虽然不再是活跃研究的主要目标，但仍在进行中，并集中在耐药变体及其抑制剂复合物的研究上。我们研究了来自其他几种来源的逆转录病毒蛋白酶，如FIV、RSV和HTLV-1。蟑螂变应原blag2是一种无活性的天冬氨酸蛋白酶，我们用不同的特异性抗体解决了两个复合物的结构。我们已经建立了一个广泛的计划来研究丝氨酸-羧基肽酶（sedolisins），这是一个家族，最初是基于在这个实验室解决的晶体结构来表征的，并且在许多不同的生物体中都有发现。我们还研究了一种细菌atp依赖性蛋白酶Lon，发现其蛋白水解结构域具有独特的折叠，从而建立了一个具有Ser-Lys催化双偶体的新蛋白酶家族。我们还解决了来自里氏木霉的天冬氨酸蛋白酶的结构，这是一种具有工业潜力的酶。具有抗病毒活性的凝集素我们已经参与了几种具有抗病毒活性的凝集素的研究，其中一些目前正在作为预防HIV感染的潜在药物进行临床前试验。我们已经解决了griffithsin的结构，作为游离蛋白质，并与许多单糖和双糖络合，解释了它与富含甘露糖的支链碳水化合物紧密结合的结构基础。我们还解决了另一种凝集素，细胞毒蛋白的原子分辨率结构。两个相关的丝氨酸蛋白激酶Rio1和Rio2参与了20S前RNA到18S核糖体RNA的加工过程。他们的晶体结构，由我们的部门解决，确定他们属于一个新的家族的底物结合区截断的激酶，尽管他们能够自磷酸化和反式磷酸化。我们已经确定了这两种细胞的自磷酸化位点。我们目前正在研究它们的催化性能和潜在的生物学作用。我们还解决了Pdcd4 c端MA3结构域的结构，解释了肿瘤抑制因子如何抑制翻译起始。细胞因子和细胞因子受体本部门一直在研究几种细胞因子的晶体结构，并在制备它们的受体复合物方面取得了进展。我们纯化并结晶了IL-10及其特异性受体的复合物，并正在研究与IL-10相关的其他几种细胞因子的复合物，如IL-19、IL-20和IL-22。晶体学方法的发展我们一直在研究与衍射数据的相位、蛋白质数据库中结构的沉积以及晶体学数据质量的提高有关的问题。一些出版物向非晶体学家解释了这项技术。

In the past several years, our work has concentrated in five distinct areas. Crystallographic studies of proteases Crystallographic studies of proteases have been an important area of research of this Section since its establishment. We have been particularly active in the investigation of structure-function relationship in aspartic proteases, including clinically important retroviral enzymes. Our studies of HIV protease, although no longer a major target of active research, are still ongoing and concentrate on the investigation of drug-resistant variants and their complexes with inhibitors. We have investigated retroviral proteases from several other sources such as FIV, RSV, and HTLV-1. Cockroach allergen Bla g 2 was shown to be an inactive aspartic protease and we solved the structures of two complexes with different specific antibodies. We have established an extensive program of investigating serine-carboxyl peptidases (sedolisins), a family that was first characterized based on crystal structures solved in this laboratory and that is found in many different organisms. We are also investigating a bacterial ATP-dependent protease Lon, finding that is proteolytic domain has a unique fold and thus establishes a new family of proteases with a Ser-Lys catalytic dyad. We have also solved the structure of an aspartic protease from Trichoderma reesei, an enzyme of industrial potential. Lectins with antiviral activity We have been involved in studies of several lectins with antiviral activities, some of them currently being in pre-clinical trials as potential drugs preventing HIV infection. We have solved the structure of griffithsin, as free protein and complexed with a number of mono- and disaccharides, explaining the structural basis for its tight binding to branched mannose-rich carbohydrates. We have also solved atomic-resolution structure of another lectin, scytovirin. Proteins involved in ribosome biogenesis and tumor suppression Two related serine protein kinases, Rio1 and Rio2, are involved in processing 20S pre-RNA to 18S ribosomal RNA. Their crystal structures, solved by our Section, established that they belong to a novel family of kinases with a truncated substrate-binding region, although they are capable of both self- and trans-phosphorylation. We have established the sites of autophosphorylation for both of them. We are currently investigating their catalytic properties and a potential biological role. We have also solved the structure of the C-terminal MA3 domain of Pdcd4, explaining how that tumor suppressor factor inhibits translation initiation. Cytokines and cytokine receptors Our Section has been investigating the crystal structures of several cytokines and has made progress in preparing their receptor complexes. We have purified and crystallized complexes of IL-10 with its specific receptor and are studying complexes of several other cytokines related to IL-10, such as IL-19, IL-20, and IL-22. Development of crystallographic methodology We have been investigating the problems related to phasing of diffraction data, deposition of structures in the Protein Data Bank, and improvement of the quality of crystallographic data. Several publications explaining the technique to non-crystallographers have been written.